For example, the design of a compound which processes the inhibitory activity of losartan (AT1 inhibitor) and Lanabecestat (a potent BACE1 inhibitor) could open new paths in the treatment of Alzheimer’s disease. The gene discussed is BACE1; the disease is Alzheimer disease.